Terms: = Lung cancer AND TRA AND Treatment
12 results:
1. Hemicricoidectomy with modified rotational thyro-crico-tracheal anastomosis: a newborn in the family of crico-tracheal resection and anastomosis techniques.
Piazza C; Lancini D; Zigliani G; Del Bon F; Tomasoni M; Montenegro C; Rampinelli V; Mattavelli D
Acta Otorhinolaryngol Ital; 2023 Dec; 43(6):382-389. PubMed ID: 37814978
[TBL] [Abstract] [Full Text] [Related]
2. [Surgical treatment of patients with chest malignancies in anti-tuberculosis hospital].
Nekrasov EV; Sinitsyn MV; Didenko GV; Vorobev AA; Ivanova DA
Khirurgiia (Mosk); 2023; (7):12-19. PubMed ID: 37379401
[TBL] [Abstract] [Full Text] [Related]
3. tra.NSTHORACIC PUNCTURE BIOPSY IN DIAGNOSTICS OF FOCAL LESIONS OF THE lung.
Drobyazgin EA; Kudryavtsev A; Chikinev YV; Zheravin AA; Blagitko EM; Shtofin SG; Shumkov OA
Vestn Khir Im I I Grek; 2016; 175(5):32-5. PubMed ID: 30422444
[TBL] [Abstract] [Full Text] [Related]
4. treatment of small cell lung cancer with tra-8 in combination with cisplatin and radiation.
Bonner JA; Willey CD; Yang ES; Dobelbower MC; Sanford LL; Bright SJ; Buchsbaum DJ; Raisch KP
Radiother Oncol; 2011 Oct; 101(1):183-9. PubMed ID: 21722984
[TBL] [Abstract] [Full Text] [Related]
5. Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics.
Goncalves A; Camerlo J; Bun H; Gravis G; Genre D; Bertucci F; Resbeut M; Pech-Gourg F; Durand A; Maraninchi D; Viens P
Anticancer Res; 2001; 21(2B):1431-7. PubMed ID: 11396227
[TBL] [Abstract] [Full Text] [Related]
6. Retinoic acid down-regulates VPAC(1) receptors and TGF-beta 3 but up-regulates TGF-beta 2 in lung cancer cells.
Jakowlew SB; Zakowicz H; Moody TW
Peptides; 2000 Dec; 21(12):1831-7. PubMed ID: 11150643
[TBL] [Abstract] [Full Text] [Related]
7. All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor- dependent signaling pathway.
Lee HY; Dohi DF; Kim YH; Walsh GL; Consoli U; Andreeff M; Dawson MI; Hong WK; Kurie JM
J Clin Invest; 1998 Mar; 101(5):1012-9. PubMed ID: 9486971
[TBL] [Abstract] [Full Text] [Related]
8. Evidence of a retinoid signaling alteration involving the activator protein 1 complex in tumorigenic human bronchial epithelial cells and non-small cell lung cancer cells.
Lee HY; Dawson MI; Claret FX; Chen JD; Walsh GL; Hong WK; Kurie JM
Cell Growth Differ; 1997 Mar; 8(3):283-91. PubMed ID: 9056670
[TBL] [Abstract] [Full Text] [Related]
9. A phase II trial of a differentiating agent (tra) with cisplatin-VP 16 chemotherapy in advanced non-small cell lung cancer.
Thiruvengadam R; Atiba JO; Azawi SH
Invest New Drugs; 1996; 14(4):395-401. PubMed ID: 9157076
[TBL] [Abstract] [Full Text] [Related]
10. Effect of v-rasH on sensitivity of NCI-H82 human small cell lung cancer cells to cisplatin, etoposide, and camptothecin.
Kaufmann SH; Kalemkerian GP; Jasti R; Mabry M
Biochem Pharmacol; 1995 Dec; 50(12):1987-93. PubMed ID: 8849324
[TBL] [Abstract] [Full Text] [Related]
11. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors.
Kim YH; Dohi DF; Han GR; Zou CP; Oridate N; Walsh GL; Nesbitt JC; Xu XC; Hong WK; Lotan R
Cancer Res; 1995 Dec; 55(23):5603-10. PubMed ID: 7585641
[TBL] [Abstract] [Full Text] [Related]
12. Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer.
Athanasiadis I; Kies MS; Miller M; Ganzenko N; Joob A; Marymont M; Rademaker A; Gradishar WJ
Clin Cancer Res; 1995 Sep; 1(9):973-9. PubMed ID: 9816069
[TBL] [Abstract] [Full Text] [Related]
